Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Max

32 indexed publications match this author name.

ORCID: 0000-0001-6896-9633
OpenAlex: https://openalex.org/A5137114818

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 14 Depression 13 Clinical Trial 9 Pharmacology 9 Mechanism of Action 8 Receptor Pharmacology 6 Treatment-Resistant Depression 4 Review Article 4 Adverse Events 3 Anxiety 3 Microdosing 3 Observational Study 3

Journals

Nature communications 3 PsyArXiv 2 ClinicalTrials.gov 2 Psychotherapy and Psychosomatics 1 JAMA Psychiatry 1 Journal of affective disorders 1 Neuroscience Applied 1 Journal of eating disorders 1

Publication history

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01 Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”PsyArXiv · 2026-03-30 Pharmacodynamic biomarker - or psychotherapeutic process? Comment on "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression".Journal of affective disorders · 2026-02-01 The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trialNeuroscience Applied · 2026-01-01 Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".Journal of eating disorders · 2025-12-04 [Acceptance of psilocybin-assisted therapy in German-speaking countries].Der Nervenarzt · 2025-11-01 Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.Nature communications · 2025-09-30 Serotonin and psilocybin activate 5-HT receptors to suppress cortical signaling through the claustrum.Nature communications · 2025-08-19 Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.Biological psychiatry · 2025-08-15 Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31 Mycelium Growth and Development of spp. Mother Cultures on Agar-Based Media.Journal of fungi (Basel, Switzerland) · 2025-06-13 A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy ParticipantsClinicalTrials.gov · 2025-06-12 Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use DisorderPsyArXiv · 2025-06-10 Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybinbioRxiv · 2025-05-30 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01 Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-12 The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active Site.Chembiochem: a European journal of chemical biology · 2024-12-02 Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.Scientific reports · 2024-11-21 A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy ParticipantsClinicalTrials.gov · 2024-10-09 Methyl transfer in psilocybin biosynthesis.Nature communications · 2024-03-28 A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.Biotechnology advances · 2023-12-01 "But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.The International journal of eating disorders · 2023-11-01 Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocolEuropean Journal of Trauma & Dissociation · 2023-10-25 [Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie-Psychiatrie · 2023-03-01 Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain: a journal of neurology · 2022-04-18 The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.Journal of psychopharmacology (Oxford, England) · 2022-03-01 Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience applied · 2022-01-01 P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-12-01 Rediscovering Psilocybin as an Antidepressive Treatment Strategy.Pharmaceuticals (Basel, Switzerland) · 2021-09-28 Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological AnalysisJournal of Humanistic Psychology · 2021-06-12 The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.Archives internationales de pharmacodynamie et de therapie · 1962-05-01

Author directory